Sign in →

Test ID BLOD1553 Prostate Health Index Reflex, Serum

Useful For

As an aid in distinguishing prostate cancer from benign prostatic conditions in men aged 50 years and older with total PSA between 4.0 and 10.0 ng/mL and digital rectal examination findings that are not suspicious for cancer

Specimen Type

Serum Red


Specimen Required


Patient Preparation:

1. Specimens for testing should be collected prior to prostate manipulations such as digital rectal examination, prostatic massage, transrectal ultrasound, and prostatic biopsy.

2. A 6-week waiting period between needle biopsy and specimen collection is recommended.

3. Specimens should not be collected from patients receiving therapy with high biotin (vitamin B7) doses (ie, >5 mg/day) until at least 8 hours following the last biotin administration.

Supplies: Sarstedt Aliquot Tube 5 mL (T914)

Collection Container/Tube: Red top (serum gel/SST are not acceptable)

Submission Container/Tube: Plastic vial

Specimen Volume: 1 mL

Collection Instructions: Within 3 hours of collection, centrifuge, aliquot serum into a plastic vial, and refrigerate. Freeze sample within 24 hours of collection and send frozen.


Specimen Minimum Volume

0.75 mL

Reject Due To

Gross hemolysis Reject
Gross icterus Reject

Specimen Stability Information

Specimen Type Temperature Time
Serum Red Frozen (preferred) 150 days
  Ambient  24 hours
  Refrigerated  24 hours

Day(s) Performed

Monday through Saturday

Report Available

1 to 3 days

Method Name

Immunoenzymatic Assay

Performing Laboratory

Mayo Clinic Laboratories in Rochester

CPT Code Information

84153 - Total PSA

84154 - Free PSA (if appropriate)

86316 - [-2]ProPSA (if appropriate)

Secondary ID

113000

Reflex Tests

Test ID Reporting Name Available Separately Always Performed
PHI13 Prostate Health Index (phi) Reflex No No

Testing Algorithm

This test begins with the analysis of prostate-specific antigen (PSA). If the PSA concentration is between 2.0 and 10.0 ng/mL, then the reflex test will be performed at an additional charge.

 

If the initial PSA concentration is between 2.0 and 10.0 ng/mL, then free PSA and [-2]pro-PSA isoform results will be reported.

 

If the initial PSA concentration is between 4.0 and 10.0 ng/mL, then the percent free PSA result and prostate health index (phi) will be calculated and reported.

 

If the initial PSA concentration is between 2.0 and 4.0 ng/mL, then the percent free PSA result and prostate health index (phi) will not be calculated or reported.

Reporting Name

Prostate Health Index Reflex, S

Reference Values

Females: Not applicable

 

PROSTATE-SPECIFIC ANTIGEN (PSA) MALES:

Age

Reference range

<40 years

≤2.0 ng/mL

40-49 years

≤2.5 ng/mL

50-59 years

≤3.5 ng/mL

60-69 years

≤4.5 ng/mL

70-79 years

≤6.5 ng/mL

≥80 years

≤7.2 ng/mL

 

PERCENT FREE PSA MALES:

When PSA is in the range of 4.0-10.0 ng/mL

% Free PSA

Probability of cancer

≤10%

56%

11-15%

28%

16-20%

20%

21-25%

16%

>25%

8%

 

PROSTATE HEALTH INDEX (phi) MALES:

When PSA is in the range of 4.0-10.0 ng/mL

phi range

Probability of cancer

95% Confidence interval

0-26.9

9.8%

5.2-15.4%

27.0-35.9

16.8%

11.3-22.2%

36.0-54.9

33.3%

26.8-39.9%

≥55.0

50.1%

39.8-61.0%

Test Classification

This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.

Forms

If not ordering electronically, complete, print, and send an Oncology Test Request (T729) with the specimen.

Sanford Laboratories - Fargo Additional Information:

SANFORD INTERFACE BUILD INFORMATION

Result Code Result Code Description
22655 Prostate Specific Antigen, S